Persones / Equip Humà

Francesc Villarroya Gombau

Buscador de publicacions

Publicacions

  • Frohlich J, Kovacovicova K, Mazza T, Emma MR, Cabibi D, Foti M, Sobolewski C, Oben JA, Peyrou M, Villarroya-Gombau F, Soresi M, Rezzani R, Cervello M, Bonomini F, Alisi A and Vinciguerra M.

    GDF11 induces mild hepatic fibrosis independent of metabolic health.

    Aging-Us . 12(20): 20024-20046. Nº de cites: 13

    [doi:10.18632/aging.104182]

  • Molonia MS, Occhiuto C, Muscarà C, Speciale A, Bashllari R, Villarroya-Gombau F, Saija A, Cimino F and Cristani M.

    Cyanidin-3-O-glucoside restores insulin signaling and reduces inflammation in hypertrophic adipocytes.

    ARCH BIOCHEM BIOPHYS . 691: 108488-108488. Nº de cites: 44

    [doi:10.1016/j.abb.2020.108488]

  • Barroso E, Rodríguez-Rodríguez R, Zarei M, Pizarro-Degado J, Planavila A, Palomer FX, Villarroya-Gombau F and Vazquez M.

    SIRT3 deficiency exacerbates fatty liver by attenuating the HIF1 alpha-LIPIN 1 pathway and increasing CD36 through Nrf2

    CELL COMMUNICATION AND SIGNALING . 18(1): 147-147. Nº de cites: 27

    [doi:10.1186/s12964-020-00640-8]

  • Domingo P, Villarroya-Gombau F, Giralt M and Domingo JC.

    Potential role of the melanocortin signaling system interference in the excess weight gain associated to some antiretroviral drugs in people living with HIV.

    INTERNATIONAL JOURNAL OF OBESITY . 44(9): 1970-1973. Nº de cites: 23

    [doi:10.1038/s41366-020-0551-5]

  • Dominguez-Gonzalez C, Badosa C, Madruga-Garrido M, Martí I, Paradas C, Ortez-Gonzalez CI, Diaz-Manera J, Berardo A, Alonso-Pérez J, Trifunov S, Cuadras-Palleja D, Kalko-Witruk SG, Blázquez-Bermejo C, Cámara Y, Martí R, Mavillard F, Martin MA, Montoya C, Ruiz-Pesini E, Villarroya-Terrade J, Montero-Sanchez R, Villarroya-Gombau F, Artuch-Iriberri R, Hirano M, Nascimento-Osorio A and Jimenez-Mallebrera C.

    Growth Differentiation Factor 15 is a potential biomarker of therapeutic response for TK2 deficient myopathy

    SCIENTIFIC REPORTS . 10(1): 10111-10111. Nº de cites: 20

    [doi:10.1038/s41598-020-66940-8]

  • Piquer-Garcia I, Cereijo R, Corral-Pérez J, Pellitero S, Martínez E, Taxerås SD, Tarascó J, Moreno P, Balibrea J, Puig-Domingo M, Serra D, Herrero L, Jiménez-Pavón D, Lerin C, Villarroya-Gombau F and Sánchez-Infantes D.

    Use of Infrared Thermography to Estimate Brown Fat Activation After a Cooling Protocol in Patients with Severe Obesity That Underwent Bariatric Surgery.

    OBESITY SURGERY . 30(6): 2375-2381. Nº de cites: 4

    [doi:10.1007/s11695-020-04502-7]

  • Peyrou M, Cereijo R, Quesada T, Campderrós L, Gavaldà-Navarro A, Liñares-Pose L, Kaschina E, Unger T, López M, Giralt M and Villarroya-Gombau F.

    The kallikrein-kinin pathway as a mechanism for auto-control of brown adipose tissue activity.

    NATURE COMMUNICATIONS . 11(1): 2132-2132. Nº de cites: 20

    [doi:10.1038/s41467-020-16009-x]

  • Díaz-Silva M, Campderrós L, Guimaraes MP, López-Bermejo A, de Zegher F, Villarroya-Gombau F and Ibañez-Toda L.

    Circulating growth-and-differentiation factor-15 in early life: relation to prenatal and postnatal growth and adiposity measurements

    PEDIATRIC RESEARCH . 87(5): 897-902. Nº de cites: 22

    [doi:10.1038/s41390-019-0633-z]

  • Piquer-Garcia I, Campderrós L, Taxerås SD, Gavaldà-Navarro A, Pardo R, Vilà-Ubach M, Pellitero S, Martínez E, Tarascó J, Moreno P, Villarroya-Terrade J, Cereijo R, González L, Reyes M, Rodriguez-Fernández S, Vives-Pi M, Lerin C, Elks CM, Stephens JM, Puig-Domingo M, Villarroya-Gombau F, Villena JA and Sánchez-Infantes D.

    A Role for Oncostatin M in the Impairment of Glucose Homeostasis in Obesity.

    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM . 105(3): 337-348. Nº de cites: 15

    [doi:10.1210/clinem/dgz090]

  • Palomer FX, Román-Azcona MS, Pizarro J, Planavila A, Villarroya-Gombau F, Valenzuela-Alcaraz BI, Crispi F, Sepúlveda-Martínez Á, Miguel-Escalada I, Ferrer J, Nistal JF, García R, Davidson MM, Barroso E and Vazquez M.

    SIRT3-mediated inhibition of FOS through histone H3 deacetylation prevents cardiac fibrosis and inflammation.

    signal transduction and targeted therapy . 5(1): 14-14. Nº de cites: 111

    [doi:10.1038/s41392-020-0114-1]